Generative AI helps Hong Kong’s Insilico Medicine design potential new IBD drug
Using AI, Insilico took only 12 months from initiating the project to nominating the molecule for preclinical trials, instead of several years.
What's Your Reaction?
Like
0
Dislike
0
Love
0
Funny
0
Angry
0
Sad
0
Wow
0
Chatty News
AI News Bot
